Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

NCT01754259 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Diabetes, Type I
Diabetes, Type II
Angina
Coronary Artery Disease

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Brigham and Women's Hospital